What Is Clinical Evidence in Speech-Language Pathology? A Scoping Review.


Journal

American journal of speech-language pathology
ISSN: 1558-9110
Titre abrégé: Am J Speech Lang Pathol
Pays: United States
ID NLM: 9114726

Informations de publication

Date de publication:
16 11 2022
Historique:
pubmed: 9 11 2022
medline: 19 11 2022
entrez: 8 11 2022
Statut: ppublish

Résumé

Two disparate models drive American speech-language pathologists' views of evidence-based practice (EBP): the American Speech-Language-Hearing Association's (2004a, 2004b) and Dollaghan's (2007). These models discuss evidence derived from clinical practice but differ in the terms used, the definitions, and discussions of its role. These concepts, which we unify as We conducted a scoping review to identify terms ascribed to clinical evidence and their descriptions. We searched the peer-reviewed, accessible, speech-language pathology intervention literature from 2005 to 2020. We extracted the terms and descriptions, from which three types of clinical evidence arose. We then used an open-coding framework to categorize positive and negative descriptions of clinical expertise and summarize the role of clinical evidence in decision making. Seventy-eight articles included a description of clinical evidence. Across publications, a single term was used to describe disparate concepts, and the same concept was given different terms, yet the concepts that authors described clustered into three categories: These results outline a shared language for SLPs to discuss their clinical evidence with researchers, families, allied professionals, and each other. Clarification of the terminology, associated definitions, and the contributions of clinical evidence to good clinical decision-making informs EBP models in speech-language pathology. https://doi.org/10.23641/asha.21498546.

Identifiants

pubmed: 36346976
doi: 10.1044/2022_AJSLP-22-00203
doi:

Types de publication

Review Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2943-2958

Auteurs

Schea Fissel Brannick (S)

Speech-Language Pathology Program, Midwestern University, Glendale, AZ.

George W Wolford (GW)

Speech-Language Pathology Program, Midwestern University, Glendale, AZ.
Department of Rehabilitation Sciences, Beaver College of Health Sciences, Appalachian State University, Boone, NC.

Laura L Wolford (LL)

Speech-Language Pathology Program, Midwestern University, Glendale, AZ.
Department of Communication Sciences and Disorders, MGH Institute of Health Professions, Boston, MA.

Kayleigh Effron (K)

Speech-Language Pathology Program, Midwestern University, Glendale, AZ.

Jennifer Buckler (J)

Speech-Language Pathology Program, Midwestern University, Glendale, AZ.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH